About this trial
The goal of this clinical trial is to test whether an established preventive intervention (group interpersonal therapy) delivered virtually shows the same benefits for preventing postpartum depression as it does when delivered in person.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
English or Spanish speaking
Less than 30 gestational weeks
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
ROSE Program: In Person
BehavioralIn-person preventative intervention for postpartum depression that includes content on building social support and communication skills in relationships, navigating the role transition to motherhood, and learning about signs and symptoms of depression after delivery.
ROSE Program: Virtual
BehavioralVirtual ROSE covers the same content (e.g. improving social support and communication) and is delivered by the same facilitators as the in-person intervention via telehealth.
Treatment groups
Trial outcomes
Primary outcomes
Symptom Checklist 20 (SCL 20)
Self reported depression scores. Possible range of scores is 0 to 80, with the higher scores indicating higher depression levels.
Symptom Checklist 20 (SCL 20)
Self reported depression scores.Possible range of scores is 0 to 80, with the higher scores indicating higher depression levels.
Symptom Checklist 20 (SCL 20)
Self reported depression scores
Symptom Checklist 20 (SCL 20)
Self reported depression scores. Possible range of scores is 0 to 80, with the higher scores indicating higher depression levels.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Denver
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Denver Health Medical Center
Collaborator